Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(2)
Other(1)

Detailed Status

Completed2
Recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

completed250%
recruiting125%
unknown125%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Characterizing Dopamine Receptor Binding in Treatment Resistant Depression

NCT03537794
completednot_applicable

Brain as a Therapeutic and Research Target in Trigeminal Neuropathic Pain

NCT03003715
completed

Wounded Spirits, Ailing Hearts: Post-Traumatic Stress Disorder and Cardiovascular Disease in Indians

NCT00073788
unknown

Alterations in Protein Synthesis Rates of Burn Patients Measured Over Time Using PET Scans

NCT00253279

Clinical Trials (4)

Showing 4 of 4 trials
NCT03537794

Characterizing Dopamine Receptor Binding in Treatment Resistant Depression

Recruiting
NCT03003715Not Applicable

Brain as a Therapeutic and Research Target in Trigeminal Neuropathic Pain

Completed
NCT00073788

Wounded Spirits, Ailing Hearts: Post-Traumatic Stress Disorder and Cardiovascular Disease in Indians

Completed
NCT00253279

Alterations in Protein Synthesis Rates of Burn Patients Measured Over Time Using PET Scans

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4